Core Insights - Holzer & Holzer, LLC is investigating whether RxSight, Inc. complied with federal securities laws following a decline in financial performance [1] - RxSight announced preliminary financial results for Q2 2025, indicating decreases in revenue, Light Delivery Devices sales, and usage of Light Adjustable Lenses [1] - The announcement led to a drop in the company's stock price [1] Financial Performance - RxSight revealed declines in revenue and sales of Light Delivery Devices for the second quarter of 2025 [1] - The company also revised its full-year 2025 guidance downward [1] Legal Context - Holzer & Holzer, LLC is a law firm specializing in representing shareholders and investors in securities litigation [3] - The firm has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]
INVESTOR ALERT: Investigation of RxSight, Inc. (RXST) Announced by Holzer & Holzer, LLC